Histopathologic Characteristics of Lung Adenocarcinomas With Epidermal Growth Factor Receptor Mutations in the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification
作者： Hyo Sup Shim , Da Hye Lee , Eun Ju Park , Se Hoon Kim
DOI: 10.5858/ARPA.2010-0493-OA
关键词:
摘要: Context.—The proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification lung adenocarcinomas has been published. Object...
allenpress.com
archivesofpathology.org
elsevier.com参考文章(29)
William D. Travis, Pathology and genetics of tumours of the lung , pleura, thymus and heart Published in <b>2004</b> in Lyon by IARC. ,(2004)
Hideaki Tsutsumida, Mitsuharu Nomoto, Masamichi Goto, Shinichi Kitajima, Ichiro Kubota, Yasunobu Hirotsu, Joeji Wakimoto, Michael A Hollingsworth, Suguru Yonezawa, A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis Modern Pathology. ,vol. 20, pp. 638- 647 ,(2007) , 10.1038/MODPATHOL.3800780
David M Jackman, Lucian R Chirieac, Pasi A Jänne, Bronchioloalveolar carcinoma: a review of the epidemiology, pathology, and treatment. Seminars in Respiratory and Critical Care Medicine. ,vol. 26, pp. 342- 352 ,(2005) , 10.1055/S-2005-871993
Oscar S. Breathnach, Naoko Ishibe, John Williams, R. Ilona Linnoila, Neil Caporaso, Bruce E. Johnson, Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung Cancer. ,vol. 86, pp. 1165- 1173 ,(1999) , 10.1002/(SICI)1097-0142(19991001)86:7<1165::AID-CNCR10>3.0.CO;2-9
Marc Ladanyi, William Pao, Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Modern Pathology. ,vol. 21, ,(2008) , 10.1038/MODPATHOL.3801018
Masayuki Noguchi, Akio Morikawa, Masanori Kawasaki, Yoshihiro Matsuno, Tesshi Yamada, Setsuo Hirohashi, Haruhiko Kondo, Yukio Shimosato, Small adenocarcinoma of the lung. Histologic characteristics and prognosis Cancer. ,vol. 75, pp. 2844- 2852 ,(1995) , 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#
Shin Myung Kang, Hyun Ju Kang, Ju Hye Shin, Hoguen Kim, Dong Hwan Shin, Se Kyu Kim, Joo-Hang Kim, Kyung Young Chung, Sung Kyu Kim, Joon Chang, Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung Cancer. ,vol. 109, pp. 581- 587 ,(2007) , 10.1002/CNCR.22413
Yasushi Yatabe, Takayuki Kosaka, Takashi Takahashi, Tetsuya Mitsudomi, EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. The American Journal of Surgical Pathology. ,vol. 29, pp. 633- 639 ,(2005) , 10.1097/01.PAS.0000157935.28066.35
Helena Linardou, Issa J. Dahabreh, Dimitrios Bafaloukos, Paris Kosmidis, Samuel Murray, Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC Nature Reviews Clinical Oncology. ,vol. 6, pp. 352- 366 ,(2009) , 10.1038/NRCLINONC.2009.62
Sanja Dacic, Yongli Shuai, Samuel Yousem, Paul Ohori, Marina Nikiforova, Clinicopathological predictors of EGFR / KRAS mutational status in primary lung adenocarcinomas Modern Pathology. ,vol. 23, pp. 159- 168 ,(2010) , 10.1038/MODPATHOL.2009.154